Harmonizing global vaccine policies and regulation is essential to ensure safe, timely, and equitable access to immunizations worldwide. National regulatory agencies and international bodies such as WHO and EMA are working to align standards on clinical evaluation, emergency use authorization, and pharmacovigilance. Streamlined regulatory pathways are supporting faster development without compromising safety. Global vaccine policies and regulation must also adapt to innovative technologies like mRNA platforms and personalized vaccines, which often lack precedent. Collaboration through initiatives like COVAX and the African Vaccine Regulatory Forum has strengthened regional oversight and accelerated approvals. Addressing disparities in regulatory capacity remains a priority, particularly in low- and middle-income countries. A cohesive framework for global vaccine policies and regulation underpins pandemic preparedness and long-term public health resilience.
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Advancing vaccine availability and equity in low-resource settings: Evidence from Awendo Sub-County, Kenya
Millicent Ochieng, Clinton Health Access Initiative, Kenya